IRONWOOD PHARMACEUTICALS INC
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Legal Proceedings
Apraglutide
On October 2, 2025, Ferring International Center S.A., or Ferring, filed a complaint against our wholly-owned subsidiary, VectivBio AG, for trade secret misappropriation and correction of patent inventorship and ownership in the U.S. District Court in the Eastern District of Texas (Case No. 2:25-cv-01001-RWS-RSP), alleging that VectivBio AG misappropriated Ferring’s technology for its own benefit and improperly filed patent applications claiming that technology without reference to Ferring’s inventorship and ownership interests. Ferring is seeking monetary damages, a declaratory order regarding ownership of certain intellectual property Ferring purports to own, an injunction ordering the transfer or control of such intellectual property, a constructive trust, and certain exemplary damages and costs. We dispute the claims raised in the complaint and intend to vigorously defend our intellectual property rights.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.